Producers of Generic Medicines and Biosimilars even More Supported by EU
Effective 1 July 2019, the EU adopted a regulation by introducing a supplementary protection certificate (SPC) manufacturing and stockpiling waiver. This waiver also applies for biosimilar versions of SPC-protected medicine during the term of the SPC. SPC’s are defined as IP rights extending patent protection for up to five years for medicines that are […]
